000			01886 a2200529 4500
005			20250515074121.0
264		0	_c20071017
008			200710s 0 0 eng d
022			_a1108-7161
040			_aNLM _beng _cNLM
100	1		_aBock, O
245	0	0	_aCommon musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention. _h[electronic resource]
260			_bJournal of musculoskeletal & neuronal interactions _c
300			_a144-8 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdministration, Oral
650	0	4	_aAged
650	0	4	_aAlendronate _xadministration & dosage
650	0	4	_aArthralgia _xchemically induced
650	0	4	_aBack Pain _xchemically induced
650	0	4	_aBone Density Conservation Agents _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aDrug Administration Schedule
650	0	4	_aEtidronic Acid _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHemiterpenes _xmetabolism
650	0	4	_aHumans
650	0	4	_aInjections, Intravenous _xadverse effects
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMale
650	0	4	_aMevalonic Acid _xmetabolism
650	0	4	_aMiddle Aged
650	0	4	_aMusculoskeletal Diseases _xchemically induced
650	0	4	_aOrganophosphorus Compounds _xmetabolism
650	0	4	_aOsteoporosis _xdrug therapy
650	0	4	_aPain _xchemically induced
650	0	4	_aRetrospective Studies
650	0	4	_aRisedronic Acid
650	0	4	_aT-Lymphocytes _xdrug effects
700	1		_aBoerst, H
700	1		_aThomasius, F E
700	1		_aDegner, C
700	1		_aStephan-Oelkers, M
700	1		_aValentine, S M
700	1		_aFelsenberg, D
773	0		_tJournal of musculoskeletal & neuronal interactions _gvol. 7 _gno. 2 _gp. 144-8
999			_c17162089 _d17162089